跳至主要内容
临床试验/CTRI/2025/04/084467
CTRI/2025/04/084467尚未招募不适用

A Randomized Comparative Clinical Study to Evaluate the Efficacy of Nashtapushpantaka Rasa and Rajahpravartini Vati in the management of Artavakshaya in Polycystic Ovarian Syndrome

Mamta Rani1 个研究点 分布在 1 个国家目标入组 134 人开始时间: 2025年1月5日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
134
试验地点
1
主要终点
Changes in Menstrual cycle length intermenstrual period amount and quality of bleeding.

研究概览

简要总结

The Study is a Randomized, Open label, parallel group comparative clinical study to evaluate and compare the efficacy of Nashtapushpantaka Rasa 250 mg bd and Rajahpravartini Vati 250 mg bd for 99 days in 134 patients with Artavakshaya in Polycystic Ovarian Syndrome will be conducted at one centre in India. Primary Outcomemeasure will be Changes in Menstrual cycle length, intermenstrual period, amount and quality of bleeding. In USG changes in ovarian volume and polycystic appearance of ovary and Changes in hormone levels serum FSH, LH, Ratio LH FSH, Prolactin, testosterone etc. at baseline and after 99 days.Secondary outcome measure will be Changes in hirsutism based on Ferriman Gallway score and Changes in Quality of Life using PCOS Qol Scale at baseline and after 99 days.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Females having PCOS assessed on Rotterdam criteria -2outof3 -oligo-and or anovulation -clinical and or biochemical signs of hyperandrogenism -polycystic ovaries in USG Patient is ready to provide signed informed consent.

排除标准

  • PCOS with heavy menstrual bleeding or menorrhagia or metrorrhagia.
  • Females less than 18 yrs.
  • and more than 40 yrs.
  • Females having primary amenorrhea.
  • Females having physiological secondary amenorrhea due to lactation.
  • Females with any organic pelvic lesions like fibroid uterus, adenomyosis, PID etc.
  • Females with hypo and hyper thyroidism.
  • Patients using oral contraceptive pills.

结局指标

主要结局

Changes in Menstrual cycle length intermenstrual period amount and quality of bleeding.

时间窗: baseline and after 99 days

In USG changes in ovarian volume and polycystic appearance of ovary.

时间窗: baseline and after 99 days

Changes in hormone levels serum FSH LH LH FSH ratio Prolactin testosterone etc

时间窗: baseline and after 99 days

次要结局

  • Changes in hirsutism based on Ferriman- Gallway score.(Changes in Quality of Life using PCOS-Qol Scale.)

研究者

发起方
Mamta Rani
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验